Northeast Pharmaceutical: The company's active pharmaceutical ingredient phosphomycin amikacin was issued a CEP certificate by the European Medicines Agency for quality management of pharmaceuticals.

Northeast Pharmaceutical announced that the company recently received a Certificate of Suitability to the monographs of the European Pharmacopoeia for the raw material drug phosphomycin amino alcohol issued by the European Medicines Agency. The acquisition of this certificate signifies that Northeast Pharmaceutical's phosphomycin amino alcohol raw material drug has officially passed the European Union's high-end registration, allowing for sales in the high-end pharmaceutical market of the EU. The company is the first domestic producer of phosphomycin amino alcohol raw material drug to obtain a CEP certificate and this CEP registration is also the first time this product has passed high-end registration in the EU.